• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 3, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Screening tools can miss sepsis in pregnancy; study urges action

Bioengineer by Bioengineer
November 21, 2018
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A woman lies in her hospital bed. Her heart rate is elevated, she has a slight fever and an elevated white blood cell count.

Could this be the beginnings of sepsis, a life-threatening reaction to an infection? Or could these simply be signs of a normal pregnancy?

Maternal sepsis, which occurs during pregnancy or postpartum, is a rare but possibly preventable complication that accounts for 12.7 percent of pregnancy-related deaths in the United States each year.

"A lot of the things you depend on to tell you there's an infection can be altered in pregnancy," says Melissa Bauer, D.O., of the department of anesthesiology. Those include a patient's vital signs such as temperature, blood pressure and respiratory rate.

Which is why many clinicians face difficulty in diagnosing sepsis in laboring women fast enough to intervene and save lives.

"Currently, there are no good ways to identify these women early," Bauer says. "We're working on figuring out the best way to do that."

To address this challenge, she and a large team at Michigan Medicine and academic medical centers across the country and in Israel combed through medical records to see which of three screening tools would do the best job of catching sepsis cases.

The paper, published in Anesthesia & Analgesia, also identifies risk factors for developing sepsis, pointing to simple interventions that could reduce the number of maternal deaths.

"We need physicians to take a good, long look at the patient and make sure that vital signs are reassessed frequently, because things can change quickly." Melissa Bauer, D.O.

The right tool for the job

The team examined three screening tools commonly used over the past two decades to identify sepsis:

  • The Systemic Inflammatory Response Syndrome (SIRS) criteria, in use from 1992 to 2016
  • The quick Sequential Organ Failure Assessment (qSOFA), recommended by the Society of Critical Care Medicine and others to replace SIRS in 2016
  • The Maternal Early Warning (MEW) criteria, designed to identify women at risk for a wide array of maternal complications, including pre-eclampsia, hemorrhage and sepsis

Bauer's team collected information on vital signs, potential risk factors for sepsis, lab values and how the women were cared for in a set of patients with sepsis and a control set without the condition.

In doing so, they found that the screening tools had vastly different sensitivities and specificities.

A screening tool's sensitivity refers to its ability to correctly identify patients with a disease. Specificity refers to the ability of the test to correctly identify patients without the disease.

The SIRS tool had the highest sensitivity but the lowest specificity, while qSOFA had the lowest sensitivity and the highest specificity.

"In my opinion, it is better for a test to have a higher sensitivity so that anyone with sepsis is caught," Bauer says. Shockingly, the researchers found that qSOFA would miss about half of the sepsis patients they reviewed.

However, specificity is still important.

"If you have poor specificity, you'll probably run into alarm fatigue, with caregivers constantly on alert for patients who don't have anything wrong," Bauer notes. "There has to be a balance."

Vigilance is key

The study also points to areas for improvement in the care of laboring mothers.

Researchers note that the Surviving Sepsis Campaign international guidelines recommend administering broad-spectrum antibiotics within the first hour of diagnosis, something that was not achieved in almost 36 percent of sepsis cases they reviewed.

And delaying treatment can be deadly: 20 percent of mothers who did not receive antibiotics within the first hour died, compared with just over 8 percent of mothers who were treated more promptly.

Bauer hypothesizes that possible reasons for slow action were delays in getting the right drugs from the pharmacy, lack of adequate IV access and the failure to triage and verify the administration of antibiotics.

Their chart review also revealed a surprising lack of data on vital signs.

"Even women who died hadn't had vital signs checked in quite a while," says Bauer, adding that care teams need to work together for the safety of every patient.

"We need physicians to take a good, long look at the patient and make sure that vital signs are reassessed frequently, because things can change quickly."

###

Media Contact

Kelly Malcom
[email protected]
@umichmedicine

http://www.med.umich.edu

https://labblog.uofmhealth.org/rounds/screening-tools-can-miss-sepsis-pregnancy-study-urges-action

Related Journal Article

http://dx.doi.org/10.1213/ANE.0000000000003709

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Risk Assessment of PAHs in Korean Sesame Oil

November 3, 2025
Sex Differences Unveiled in Hamster Hypertension Study

Sex Differences Unveiled in Hamster Hypertension Study

November 3, 2025

AI Misuse in Stem Cell Research: A Comparative Study

November 3, 2025

Modular High-Throughput Tools Boost Chlamydomonas Chloroplast Research

November 3, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1296 shares
    Share 518 Tweet 324
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    313 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    204 shares
    Share 82 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    137 shares
    Share 55 Tweet 34

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Exposure Science 2024: Health Risks to Vulnerable Groups

Dr. Xin Jin Awarded 2026 Peter Gruss Young Investigator Prize

Gender Differences in Hamster Hypertension and Kidney Damage

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.